Organon Pharma Indonesia Tbk. vs Wahana Ottomitra Multiartha Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Wahana Ottomitra Multiartha Tbk. trades at Rp296 (market cap 940B, 3.2M 24h volume). The key difference: Wahana Ottomitra Multiartha Tbk. is far larger — about 9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WOMF | |
|---|---|---|
Market Cap | 104.4B | 940B |
Volume | — | 3.2M |
Lot | — | 31.97K |
Turnover | — | 980.29M |
Average Price | — | 306.64 |
Value | — | 980.29M |
Indicative Equilibrium Price | — | 296 |
Indicative Equilibrium Volume | — | 244 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Wahana Ottomitra Multiartha Tbk (the Company) formerly PT Jakarta Tokyo Leasing, was established based on notarial deed No.179 dated March 23, 1982 of Kartini Muljadi SH, notary in Jakarta. The name was changed to PT Fuji Semeru Leasing on Dec 15 1982 and changed to PT Wahana Ometraco Multiartha on March 15, 2000. On November 30, 2004, the Company obtained the Effective Letter of the Registration Statement for the Initial Public Offering of Shares from the Chairman of the Capital Market Supervisory Agency (BAPEPAM) in its Letter No.S-3551/PM/2004. The Companys shares were listed on the Jakarta and Surabaya Stock Exchange (now Indonesia Stock Exchange) on December 13, 2004.
Read more on WOMF →